|
gptkbp:instance_of
|
gptkb:Clinical_Trials
|
|
gptkbp:analysis
|
intention-to-treat analysis
|
|
gptkbp:business_model
|
obtained from institutional review boards
|
|
gptkbp:clinical_trial
|
NCT01205776
|
|
gptkbp:collection
|
clinical assessments and questionnaires
|
|
gptkbp:completed
|
gptkb:2018
|
|
gptkbp:concluded_on
|
PCI is a viable option for selected patients.
|
|
gptkbp:criteria
|
patients with left main coronary artery disease
patients with stable coronary artery disease
|
|
gptkbp:events
|
5 years
|
|
gptkbp:finale_date
|
quality of life
death, myocardial infarction, or stroke
|
|
gptkbp:focuses_on
|
coronary artery disease
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
The EXCEL Trial
|
|
gptkbp:investigates
|
gptkb:Dr._Shamir_Mehta
|
|
gptkbp:involved_patients
|
patients with diabetes
|
|
gptkbp:is_compared_to
|
CABG and PCI
|
|
gptkbp:is_funded_by
|
gptkb:National_Institutes_of_Health
|
|
gptkbp:location
|
multiple centers worldwide
|
|
gptkbp:measured_outcomes
|
major adverse cardiac events
|
|
gptkbp:published_in
|
gptkb:The_New_England_Journal_of_Medicine
|
|
gptkbp:result
|
gptkb:2018
showed similar outcomes
|
|
gptkbp:sampled_in
|
patients into two groups
|
|
gptkbp:sponsored_by
|
gptkb:Cardiovascular_Research_Foundation
|
|
gptkbp:started_in
|
gptkb:2010
|
|
gptkbp:student_enrollment
|
approximately 1,900 patients
|
|
gptkbp:used_control
|
coronary artery bypass grafting
|
|
gptkbp:used_intervention
|
percutaneous coronary intervention
|
|
gptkbp:was_a_demonstration_of
|
non-inferiority of PCI to CABG
|
|
gptkbp:bfsParent
|
gptkb:The_New_England_Journal_of_Medicine
|
|
gptkbp:bfsLayer
|
6
|